{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:19:50Z","timestamp":1780492790980,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatic adenomas (HA) are benign neoplasms of the liver that have small risks of hemorrhage and malignant transformation. While the association between obesity and the development of HAs is increasingly recognized, the impact of bariatric surgery on HA regression is poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients with a pre-operative diagnosis of HA who underwent primary bariatric surgery (sleeve gastrectomy or Roux-en-Y gastric bypass) at a single quaternary academic medical center from 2012\u00a0to 2024 were retrospectively queried and combined with all previously reported cases obtained via a systematic review of the literature. Patient clinical characteristics, including pre-operative and post-operative body mass index (BMI) and HA size, were extracted. Kendall\u2019s Tau-b correlation and fractional probit regression were used to assess the relationship between weight loss and HA size change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The institutional review identified three patients, and the systematic review yielded five studies totaling seven patients. In the combined cohort (mean age 34.8\u00a0years), the average pre-operative BMI was 44.48\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and decreased to 32.19\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      post-operatively, representing 68.18% excess weight loss (%EWL). Mean HA size decreased from 4.49\u00a0cm to 1.55\u00a0cm (56.46% reduction, SD 43.68), with 40% of patients experiencing complete regression. %EWL was significantly associated with HA size reduction (Kendall\u2019s Tau-b: 0.5528;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047). Marginal effects following fractional probit regression analysis showed that each additional percentage increase in %EWL was associated with 0.76% HA size reduction (95% CI: -1.18, -0.34; p\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this combined case series and systematic review of the literature, bariatric surgery was associated with high rates of HA regression. Given the additional benefits of weight loss from bariatric surgery and the significant morbidity associated with liver resection, bariatric surgery could be considered as an initial management option for obese patients with HA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-025-12350-8","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T20:23:58Z","timestamp":1762806238000},"page":"1147-1156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic adenoma regression after bariatric surgery: a case series and systematic review"],"prefix":"10.1007","volume":"40","author":[{"given":"Ian C.","family":"Garbarine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrena F.","family":"Noria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2373-8433","authenticated-orcid":false,"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"12350_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","volume":"242","author":"JB Rooks","year":"1979","unstructured":"Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644\u2013648","journal-title":"JAMA"},{"key":"12350_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJM197602262940904","volume":"294","author":"HA Edmondson","year":"1976","unstructured":"Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470\u2013472","journal-title":"N Engl J Med"},{"issue":"5","key":"12350_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/liv.14074","volume":"39","author":"MPD Haring","year":"2019","unstructured":"Haring MPD, Gouw ASH, de Haas RJ, Cuperus FJC, de Jong KP, de Meijer VE (2019) The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: a retrospective cohort study. Liver Int 39(5):905\u2013913","journal-title":"Liver Int"},{"key":"12350_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11605-018-3917-4","volume":"23","author":"DI Tsilimigras","year":"2019","unstructured":"Tsilimigras DI, Rahnemai-Azar AA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM (2019) Current approaches in the management of hepatic adenomas. J Gastrointest Surg 23:199\u2013209","journal-title":"J Gastrointest Surg"},{"key":"12350_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.4254\/wjh.v7.i25.2603","volume":"7","author":"A Vijay","year":"2015","unstructured":"Vijay A, Elaffandi A, Khalaf H (2015) Hepatocellular adenoma: an update. World J Hepatol 7:2603\u20132609","journal-title":"World J Hepatol"},{"key":"12350_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","volume":"85","author":"R Pasquali","year":"2006","unstructured":"Pasquali R (2006) Obesity and androgens: facts and perspectives. Fertil Steril 85:1319\u20131340","journal-title":"Fertil Steril"},{"key":"12350_CR7","unstructured":"Ylli D, Sidhu S, Parikh T, Burman KD (2000) Endocrine changes in obesity. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferr\u00e8re B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (eds) Endotext. South Dartmouth, MA: MDText.com"},{"key":"12350_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1055\/s-2002-38265","volume":"34","author":"C B\u00e9langer","year":"2002","unstructured":"B\u00e9langer C, Luu-The V, Dupont P, Tchernof A (2002) Adipose tissue intracrinology: potential importance of local androgen\/estrogen metabolism in the regulation of adiposity. Horm Metab Res 34:737\u2013745","journal-title":"Horm Metab Res"},{"key":"12350_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/liv.14547","volume":"40","author":"AJ Klompenhouwer","year":"2020","unstructured":"Klompenhouwer AJ, de Man RA, Dioguardi Burgio M, Vilgrain V, Zucman-Rossi J, Ijzermans JNM (2020) New insights in the management of hepatocellular adenoma. Liver Int 40:1529\u20131537","journal-title":"Liver Int"},{"key":"12350_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","volume":"65","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol. 65:386\u2013398","journal-title":"J Hepatol."},{"key":"12350_CR11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/hpb.12496","volume":"17","author":"K Hoffmann","year":"2015","unstructured":"Hoffmann K, Unsinn M, Hinz U, Weiss KH, Waldburger N, Longerich T, Radeleff B, Schirmacher P, B\u00fcchler MW, Schemmer P (2015) Outcome after a liver resection of benign lesions. HPB (Oxford) 17:994\u20131000","journal-title":"HPB (Oxford)"},{"key":"12350_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.amjsurg.2015.06.010","volume":"211","author":"TE Newhook","year":"2016","unstructured":"Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM (2016) Morbidity and mortality of hepatectomy for benign liver tumors. Am J Surg 211:102\u2013108","journal-title":"Am J Surg"},{"key":"12350_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.hpb.2016.06.011","volume":"18","author":"A Laurent","year":"2016","unstructured":"Laurent A, Dokmak S, Nault JC, Pruvot FR, Fabre JM, Letoublon C, Bachellier P, Capussotti L, Farges O, Mabrut JY, Le Treut YP, Ayav A, Suc B, Soubrane O, Mentha G, Popescu I, Montorsi M, Demartines N, Belghiti J, Torzilli G, Cherqui D, Hardwigsen J (2016) European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group. HPB (Oxford) 18:748\u2013755","journal-title":"HPB (Oxford)"},{"key":"12350_CR14","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1007\/s11605-020-04780-7","volume":"24","author":"EA Armstrong","year":"2020","unstructured":"Armstrong EA, Ejaz A, Sarna A, Conteh L, Tsung A, Pawlik TM, Cloyd JM (2020) A cross-sectional evaluation of quality of life among patients with hepatic adenomas. J Gastrointest Surg 24:2862\u20132864","journal-title":"J Gastrointest Surg"},{"key":"12350_CR15","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s00464-018-6422-7","volume":"33","author":"R Sebastian","year":"2019","unstructured":"Sebastian R, Howell MH, Chang KH, Adrales G, Magnuson T, Schweitzer M, Nguyen H (2019) Robot-assisted versus laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a propensity score-matched comparative analysis using the 2015\u20132016 MBSAQIP database. Surg Endosc 33:1600\u20131612","journal-title":"Surg Endosc"},{"key":"12350_CR16","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL (2020) Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief. 1\u20138"},{"key":"12350_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1478-3231.2012.02786.x","volume":"32","author":"P Bioulac-Sage","year":"2012","unstructured":"Bioulac-Sage P, Taouji S, Possenti L, Balabaud C (2012) Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int 32:1217\u20131221","journal-title":"Liver Int"},{"key":"12350_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/MEG.0000000000000930","volume":"29","author":"MEE Br\u00f6ker","year":"2017","unstructured":"Br\u00f6ker MEE, Gaspersz MP, Klompenhouwer AJ, Hansen BE, Terkivatan T, Taimr P, Dwarkasing R, Thomeer MGJ, de Man RA (2017) Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI. Eur J Gastroenterol Hepatol 29:1183\u20131188","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"12350_CR19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-2036.2011.04772.x","volume":"34","author":"C Bunchorntavakul","year":"2011","unstructured":"Bunchorntavakul C, Bahirwani R, Drazek D, Soulen MC, Siegelman ES, Furth EE, Olthoff K, Shaked A, Reddy KR (2011) Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 34:664\u2013674","journal-title":"Aliment Pharmacol Ther"},{"key":"12350_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1467-789X.2010.00740.x","volume":"11","author":"JC Barte","year":"2010","unstructured":"Barte JC, ter Bogt NC, Bogers RP, Teixeira PJ, Blissmer B, Mori TA, Bemelmans WJ (2010) Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review. Obes Rev 11:899\u2013906","journal-title":"Obes Rev"},{"key":"12350_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.metabol.2015.08.006","volume":"64","author":"CA Anastasiou","year":"2015","unstructured":"Anastasiou CA, Karfopoulou E, Yannakoulia M (2015) Weight regaining: from statistics and behaviors to physiology and metabolism. Metabolism 64:1395\u20131407","journal-title":"Metabolism"},{"key":"12350_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jama.2020.12567","volume":"324","author":"DE Arterburn","year":"2020","unstructured":"Arterburn DE, Telem DA, Kushner RF, Courcoulas AP (2020) Benefits and risks of bariatric surgery in adults: a review. JAMA 324:879\u2013887","journal-title":"JAMA"},{"key":"12350_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11695-020-04889-3","volume":"31","author":"V Mocanu","year":"2021","unstructured":"Mocanu V, Mihajlovic I, Dang JT, Birch DW, Karmali S, Switzer NJ (2021) Evolving trends in North American gastric bypass delivery: a retrospective MBSAQIP analysis of technical factors and outcomes from 2015 to 2018. Obes Surg 31:151\u2013158","journal-title":"Obes Surg"},{"key":"12350_CR24","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.soard.2020.06.043","volume":"16","author":"J Goonawardena","year":"2020","unstructured":"Goonawardena J, Ratnayake C, Cheung KT, Fox A (2020) Should bariatric surgery be offered for hepatocellular adenomas in obese patients? Surg Obes Relat Dis 16:2117\u20132124","journal-title":"Surg Obes Relat Dis"},{"key":"12350_CR25","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/liv.13934","volume":"38","author":"TJG Gevers","year":"2018","unstructured":"Gevers TJG, Marcel Spanier BW, Veendrick PB, Vrolijk JM (2018) Regression of hepatocellular adenoma after bariatric surgery in severe obese patients. Liver Int 38:2134\u20132136","journal-title":"Liver Int"},{"key":"12350_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.soard.2018.01.006","volume":"14","author":"I Khaoudy","year":"2018","unstructured":"Khaoudy I, Rebibo L, Regimbeau JM (2018) Is bariatric surgery a potential new treatment for large inflammatory hepatocellular adenomas in obese patients? Surg Obes Relat Dis 14:535\u2013538","journal-title":"Surg Obes Relat Dis"},{"key":"12350_CR27","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/liv.12925","volume":"35","author":"S Dokmak","year":"2015","unstructured":"Dokmak S, Belghiti J (2015) Will weight loss become a future treatment of hepatocellular adenoma in obese patients? Liver Int 35:2228\u20132232","journal-title":"Liver Int"},{"key":"12350_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573\u2013577","journal-title":"Ann Intern Med"},{"key":"12350_CR29","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18:2127\u20132133","journal-title":"JBI Evid Synth"},{"key":"12350_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s11695-008-9700-y","volume":"20","author":"G Bonanomi","year":"2010","unstructured":"Bonanomi G, Mandal\u00e0 L, Maruzzelli L (2010) Laparoscopic staged adjustable gastric banding and liver resection in morbidly obese patient. Obes Surg 20:1186\u20131190","journal-title":"Obes Surg"},{"key":"12350_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.orcp.2021.03.008","volume":"15","author":"ACB Dantas","year":"2021","unstructured":"Dantas ACB, Santo Filho MA, Jeismann VB, de Faria LL, Muniz RR, Rocha MS, Herman P, Santo MA (2021) Long-term complete remission of large hepatocellular adenoma after bariatric surgery. Obes Res Clin Pract 15:300\u2013302","journal-title":"Obes Res Clin Pract"},{"key":"12350_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.826772","volume":"13","author":"H Dauleh","year":"2022","unstructured":"Dauleh H, Soliman A, Haris B, Khalifa A, Al Khori N, Hussain K (2022) Case report: hepatic adenomatosis in a patient with Prader-Willi syndrome. Front Endocrinol (Lausanne) 13:826772","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12350_CR33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.gassur.2024.03.010","volume":"28","author":"H Aziz","year":"2024","unstructured":"Aziz H, Underwood PW, Gosse MD, Afyouni S, Kamel I, Pawlik TM (2024) Hepatic adenoma: evolution of a more individualized treatment approach. J Gastrointest Surg 28:975\u2013982","journal-title":"J Gastrointest Surg"},{"key":"12350_CR34","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.14309\/ajg.0000000000002857","volume":"119","author":"C Frenette","year":"2024","unstructured":"Frenette C, Mendiratta-Lala M, Salgia R, Wong RJ, Sauer BG, Pillai A (2024) ACG clinical guideline: focal liver lesions. Am J Gastroenterol 119:1235\u20131271","journal-title":"Am J Gastroenterol"},{"key":"12350_CR35","doi-asserted-by":"publisher","first-page":"e053559","DOI":"10.1136\/bmjopen-2021-053559","volume":"12","author":"CAJ Oudmaijer","year":"2022","unstructured":"Oudmaijer CAJ, Berk KA, van der Louw E, de Man R, van der Lelij AJ, Hoeijmakers JHJ (2022) KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study. BMJ Open 12:e053559","journal-title":"BMJ Open"},{"key":"12350_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/gutjnl-2022-328185","volume":"72","author":"FF Anh\u00ea","year":"2023","unstructured":"Anh\u00ea FF, Zlitni S, Zhang SY, Choi BS, Chen CY, Foley KP, Barra NG, Surette MG, Biertho L, Richard D, Tchernof A, Lam TKT, Marette A, Schertzer J (2023) Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity. Gut 72:460\u2013471","journal-title":"Gut"},{"key":"12350_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI78016","volume":"125","author":"PM Coen","year":"2015","unstructured":"Coen PM, Tanner CJ, Helbling NL, Dubis GS, Hames KC, Xie H, Eid GM, Stefanovic-Racic M, Toledo FG, Jakicic JM, Houmard JA, Goodpaster BH (2015) Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity. J Clin Invest 125:248\u2013257","journal-title":"J Clin Invest"},{"key":"12350_CR38","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.surge.2023.07.006","volume":"22","author":"O Elhelw","year":"2024","unstructured":"Elhelw O, Ragavan S, Majeed W, Alkhaffaf B, Mohammed N, Senapati S, Ammori BJ, Robinson JA, Syed AA (2024) The impact of bariatric surgery on liver enzymes in people with obesity: a 5-year observational study. Surgeon 22:e26\u2013e33","journal-title":"Surgeon"},{"key":"12350_CR39","doi-asserted-by":"publisher","first-page":"2059245","DOI":"10.1155\/2016\/2059245","volume":"2016","author":"JJ Nostedt","year":"2016","unstructured":"Nostedt JJ, Switzer NJ, Gill RS, Dang J, Birch DW, de Gara C, Bailey RJ, Karmali S (2016) The effect of bariatric surgery on the spectrum of fatty liver disease. Can J Gastroenterol Hepatol 2016:2059245","journal-title":"Can J Gastroenterol Hepatol"},{"key":"12350_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00164","volume":"5","author":"A Sasaki","year":"2014","unstructured":"Sasaki A, Nitta H, Otsuka K, Umemura A, Baba S, Obuchi T, Wakabayashi G (2014) Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne) 5:164","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12350_CR41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27:740\u2013756","journal-title":"Cell Metab"},{"key":"12350_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2024.04.029","volume":"167","author":"L Wang","year":"2024","unstructured":"Wang L, Berger NA, Kaelber DC, Xu R (2024) Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes. Gastroenterology 167:689\u2013703","journal-title":"Gastroenterology"},{"key":"12350_CR43","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.3748\/wjg.v20.i40.14821","volume":"20","author":"XC Wang","year":"2014","unstructured":"Wang XC, Gusdon AM, Liu H, Qu S (2014) Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. World J Gastroenterol 20:14821\u201314830","journal-title":"World J Gastroenterol"},{"key":"12350_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100813","volume":"3","author":"AD Gutierrez","year":"2022","unstructured":"Gutierrez AD, Gao Z, Hamidi V, Zhu L, Saint Andre KB, Riggs K, Ruscheinsky M, Wang H, Yu Y, Miller C 3rd, Vasquez H, Taegtmeyer H, Kolonin MG (2022) Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes. Cell Rep Med 3:100813","journal-title":"Cell Rep Med"},{"key":"12350_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.soard.2017.11.012","volume":"14","author":"JR Imbus","year":"2018","unstructured":"Imbus JR, Voils CI, Funk LM (2018) Bariatric surgery barriers: a review using Andersen\u2019s model of health services use. Surg Obes Relat Dis 14:404\u2013412","journal-title":"Surg Obes Relat Dis"},{"key":"12350_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.orcp.2020.07.001","volume":"14","author":"E Iuzzolino","year":"2020","unstructured":"Iuzzolino E, Kim Y (2020) Barriers impacting an individuals decision to undergo bariatric surgery: a systematic review. Obes Res Clin Pract 14:310\u2013320","journal-title":"Obes Res Clin Pract"},{"key":"12350_CR47","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.soard.2017.01.009","volume":"13","author":"AN Martin","year":"2017","unstructured":"Martin AN, Marino M, Killerby M, Rosselli-Risal L, Isom KA, Robinson MK (2017) Impact of Spanish-language information sessions on Spanish-speaking patients seeking bariatric surgery. Surg Obes Relat Dis 13:1025\u20131031","journal-title":"Surg Obes Relat Dis"},{"key":"12350_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.amjsurg.2021.12.022","volume":"224","author":"JA Murtha","year":"2022","unstructured":"Murtha JA, Alagoz E, Breuer CR, Finn A, Raffa SD, Voils CI, Funk LM (2022) Individual-level barriers to bariatric surgery from patient and provider perspectives: a qualitative study. Am J Surg 224:429\u2013436","journal-title":"Am J Surg"},{"key":"12350_CR49","volume":"2016","author":"D Westerveld","year":"2016","unstructured":"Westerveld D, Yang D (2016) Through thick and thin: identifying barriers to bariatric surgery, weight loss maintenance, and tailoring obesity treatment for the future. Surg Res Pract 2016:8616581","journal-title":"Surg Res Pract"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12350-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:02:54Z","timestamp":1770408174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12350-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["12350"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12350-8","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Timothy M Pawlik, Sabrena Noria, Jordan Cloyd, Ian C Garbarine, and Ms. Amanda K Walsh have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}